Allstate (NYSE:ALL) Given New $225.00 Price Target at Keefe, Bruyette & Woods

Allstate (NYSE:ALL) had its price objective lifted by Keefe, Bruyette & Woods from $222.00 to $225.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have an outperform rating on the insurance provider’s stock.

ALL has been the subject of several other reports. BMO Capital Markets raised their target price on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. The Goldman Sachs Group lifted their target price on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Bank of America increased their price target on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. StockNews.com downgraded Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. Finally, Roth Mkm reiterated a “buy” rating and issued a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $209.50.

Allstate Stock Performance

NYSE ALL opened at $188.69 on Wednesday. The company’s fifty day moving average is $188.89 and its two-hundred day moving average is $175.59. Allstate has a 52-week low of $127.93 and a 52-week high of $198.79. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The firm has a market capitalization of $49.97 billion, a price-to-earnings ratio of 12.22, a P/E/G ratio of 1.73 and a beta of 0.48.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same period last year, the business earned $0.81 earnings per share. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. Equities research analysts forecast that Allstate will post 15.23 EPS for the current year.

Insider Activity

In related news, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares in the company, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock valued at $34,967,665 over the last three months. 1.80% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Northwest Investment Counselors LLC bought a new stake in Allstate in the third quarter valued at approximately $28,000. Catalyst Capital Advisors LLC acquired a new stake in Allstate during the 3rd quarter worth $29,000. Versant Capital Management Inc lifted its holdings in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in Allstate in the second quarter valued at about $38,000. Finally, MCF Advisors LLC increased its holdings in shares of Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.